Symbols / NKTX Stock $2.94 -5.02% Nkarta, Inc.

Healthcare • Biotechnology • United States • NMS
NKTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Stock Fundamentals
Scroll to Statements
Market Cap 209.24M Enterprise Value 20.43M Income -104.08M Sales — Book/sh 4.39 Cash/sh 3.88
Dividend Yield — Payout 0.00% Employees 108 IPO — P/E — Forward P/E -1.64
PEG — P/S — P/B 0.67 P/C — EV/EBITDA -0.19 EV/Sales —
Quick Ratio 12.41 Current Ratio 12.69 Debt/Eq 24.47 LT Debt/Eq — EPS (ttm) -1.41 EPS next Y -1.79
EPS Growth — Revenue Growth — Earnings 2026-05-14 ROA -15.99% ROE -28.90% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 71.29M Shs Float 56.62M Short Float 10.26%
Short Ratio 8.41 Short Interest — 52W High 3.65 52W Low 1.63 Beta 0.67 Avg Volume 779.56K
Volume 805.06K Target Price $14.20 Recom Strong_buy Prev Close $3.09 Price $2.94 Change -5.02%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.20
Mean price target
2. Current target
$2.94
Latest analyst target
3. DCF / Fair value
$-13.53
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.94
Low
$8.00
High
$25.00
Mean
$14.20

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-31 main Mizuho Outperform → Outperform $12
2026-03-26 main Needham Buy → Buy $11
2025-11-11 main Stifel Buy → Buy $11
2025-08-14 main Stifel Buy → Buy $12
2025-08-13 reit Needham Buy → Buy $10
2025-06-10 main Mizuho Outperform → Outperform $14
2025-05-15 main Needham Buy → Buy $10
2025-05-15 down William Blair Outperform → Market Perform —
2025-04-09 reit Needham Buy → Buy $11
2025-03-27 main Stifel Buy → Buy $14
2025-03-27 reit Needham Buy → Buy $11
2025-03-27 reit HC Wainwright & Co. Buy → Buy $18
2024-11-21 main Mizuho Outperform → Outperform $16
2024-11-11 main HC Wainwright & Co. Buy → Buy $18
2024-11-08 main Needham Buy → Buy $11
2024-08-15 main HC Wainwright & Co. Buy → Buy $22
2024-08-14 reit Needham Buy → Buy $13
2024-08-14 up Raymond James Outperform → Strong Buy $16
2024-07-24 reit HC Wainwright & Co. Buy → Buy $23
2024-06-28 reit Needham Buy → Buy $13
News
RSS: Latest NKTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-15 HASTINGS PAUL J Chief Executive Officer — 26,046 $2.07 $53,915
2026-01-15 MAHMOOD NADIR AHMEDUDDIN President — 5,649 $2.07 $11,693
2026-01-06 HASTINGS PAUL J Chief Executive Officer — 94,000 $0.00 $0
2026-01-06 MAHMOOD NADIR AHMEDUDDIN President — 80,000 $0.00 $0
2026-01-06 ROSE SHAWN MARSHALL Officer — 70,000 $0.00 $0
2025-06-18 HASTINGS PAUL J Chief Executive Officer — 1,790 $1.79 $3,204
2025-01-15 HASTINGS PAUL J Chief Executive Officer — 17,378 $2.20 $38,232
2025-01-15 HAGER ALICIA J Officer — 9,584 $2.20 $21,085
2025-01-15 BRANDENBERGER RALPH ERIK Chief Technology Officer — 7,447 $2.20 $16,383
2025-01-15 SHOOK DAVID M.D. Officer — 8,638 $2.20 $19,004
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
122.00
-4.83%
128.19
-2.63%
131.65
+10.67%
118.95
Research And Development
90.43
-6.53%
96.74
-0.03%
96.77
+6.46%
90.90
Selling General And Administration
31.57
+0.38%
31.45
-9.83%
34.88
+24.30%
28.06
General And Administrative Expense
31.57
+0.38%
31.45
-9.83%
34.88
+24.30%
28.06
Other Gand A
31.57
+0.38%
31.45
-9.83%
34.88
+24.30%
28.06
Total Expenses
122.00
-4.83%
128.19
-2.63%
131.65
+10.67%
118.95
Operating Income
-122.00
+4.83%
-128.19
+2.63%
-131.65
-10.67%
-118.95
Total Operating Income As Reported
-122.00
+4.83%
-128.19
+2.63%
-131.65
-10.67%
-118.95
EBITDA
-112.80
+5.24%
-119.04
+5.36%
-125.78
-8.14%
-116.32
Normalized EBITDA
-112.80
+5.24%
-119.04
+5.36%
-125.78
-8.14%
-116.32
Reconciled Depreciation
9.19
+0.45%
9.15
+55.94%
5.87
+122.56%
2.64
EBIT
-122.00
+4.83%
-128.19
+2.63%
-131.65
-10.67%
-118.95
Net Income
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Pretax Income
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Net Non Operating Interest Income Expense
15.49
-19.79%
19.32
+36.93%
14.11
+152.45%
5.59
Net Interest Income
15.49
-19.79%
19.32
+36.93%
14.11
+152.45%
5.59
Interest Income Non Operating
15.49
-19.79%
19.32
+36.93%
14.11
+152.45%
5.59
Interest Income
15.49
-19.79%
19.32
+36.93%
14.11
+152.45%
5.59
Other Income Expense
2.42
+2680.46%
0.09
+107.14%
0.04
+108.94%
-0.47
Other Non Operating Income Expenses
2.42
+2680.46%
0.09
+107.14%
0.04
+108.94%
-0.47
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Net Income From Continuing Operation Net Minority Interest
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Net Income From Continuing And Discontinued Operation
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Net Income Continuous Operations
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Normalized Income
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Net Income Common Stockholders
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Diluted EPS
-1.41
+11.88%
-1.60
+33.33%
-2.40
+8.05%
-2.61
Basic EPS
-1.41
+11.88%
-1.60
+33.33%
-2.40
+8.05%
-2.61
Basic Average Shares
73.99
+9.03%
67.87
+38.46%
49.01
+12.34%
43.63
Diluted Average Shares
73.99
+9.03%
67.87
+38.46%
49.01
+12.34%
43.63
Diluted NI Availto Com Stockholders
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
404.21
-19.35%
501.20
+32.28%
378.88
-19.89%
472.94
Current Assets
282.51
+3.36%
273.34
+8.01%
253.07
-29.84%
360.69
Cash Cash Equivalents And Short Term Investments
276.28
+3.34%
267.35
+7.72%
248.19
-29.52%
352.14
Cash And Cash Equivalents
39.63
+42.19%
27.87
-10.20%
31.04
-17.21%
37.49
Other Short Term Investments
236.65
-1.18%
239.48
+10.28%
217.15
-30.99%
314.65
Prepaid Assets
3.82
+17.54%
3.25
-0.43%
3.26
-41.90%
5.62
Other Current Assets
2.41
-11.74%
2.73
+68.93%
1.62
-44.73%
2.93
Total Non Current Assets
121.70
-46.59%
227.87
+81.11%
125.81
+12.08%
112.25
Net PPE
101.15
-8.60%
110.67
-7.21%
119.28
+10.79%
107.66
Gross PPE
130.10
-1.08%
131.52
+0.42%
130.97
+15.41%
113.48
Accumulated Depreciation
-28.95
-38.89%
-20.84
-78.27%
-11.69
-100.77%
-5.82
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.04
-9.48%
1.15
+0.09%
1.15
+48.26%
0.78
Construction In Progress
10.57
-2.34%
10.82
+20.85%
8.95
-81.97%
49.66
Other Properties
52.01
-1.74%
52.93
-2.43%
54.25
-7.51%
58.65
Leases
66.49
-0.20%
66.62
+0.00%
66.62
+1413.36%
4.40
Investments And Advances
16.11
-85.41%
110.39
0.00
—
Other Non Current Assets
4.44
-34.72%
6.80
+4.01%
6.54
+42.37%
4.59
Total Liabilities Net Minority Interest
91.88
-1.44%
93.23
-11.72%
105.60
+4.83%
100.73
Current Liabilities
22.27
+17.70%
18.92
-18.92%
23.33
+5.82%
22.05
Payables And Accrued Expenses
9.31
+88.16%
4.95
-53.04%
10.54
-5.11%
11.11
Payables
2.09
+227.43%
0.64
-82.59%
3.67
+108.12%
1.76
Accounts Payable
2.09
+227.43%
0.64
-82.59%
3.67
+108.12%
1.76
Current Accrued Expenses
7.22
+67.55%
4.31
-37.29%
6.87
-26.44%
9.35
Pensionand Other Post Retirement Benefit Plans Current
6.07
-23.40%
7.92
+17.79%
6.72
+0.46%
6.69
Current Debt And Capital Lease Obligation
6.89
+13.87%
6.05
-0.31%
6.07
+42.83%
4.25
Current Capital Lease Obligation
6.89
+13.87%
6.05
-0.31%
6.07
+42.83%
4.25
Total Non Current Liabilities Net Minority Interest
69.62
-6.31%
74.31
-9.68%
82.27
+4.56%
78.69
Long Term Debt And Capital Lease Obligation
69.53
-6.32%
74.22
-9.78%
82.27
+4.56%
78.69
Long Term Capital Lease Obligation
69.53
-6.32%
74.22
-9.78%
82.27
+4.56%
78.69
Other Non Current Liabilities
0.09
+0.00%
0.09
—
—
Stockholders Equity
312.32
-23.45%
407.98
+49.29%
273.29
-26.58%
372.21
Common Stock Equity
312.32
-23.45%
407.97
+49.28%
273.29
-26.58%
372.21
Capital Stock
0.01
+0.00%
0.01
+40.00%
0.01
+0.00%
0.01
Common Stock
0.00
0.00
-100.00%
0.01
+0.00%
0.01
Preferred Stock
0.01
+0.00%
0.01
0.00
0.00
Share Issued
71.08
+0.61%
70.65
+43.64%
49.18
+0.62%
48.88
Ordinary Shares Number
71.08
+0.61%
70.65
+43.64%
49.18
+0.62%
48.88
Additional Paid In Capital
960.22
+0.91%
951.52
+34.26%
708.71
+2.59%
690.81
Retained Earnings
-648.31
-19.13%
-544.22
-24.98%
-435.43
-36.96%
-317.93
Gains Losses Not Affecting Retained Earnings
0.41
-39.61%
0.67
+8325.00%
0.01
+101.18%
-0.68
Other Equity Adjustments
0.41
-39.61%
0.67
+8325.00%
0.01
+101.18%
-0.68
Total Equity Gross Minority Interest
312.32
-23.45%
407.98
+49.29%
273.29
-26.58%
372.21
Total Capitalization
312.32
-23.45%
407.98
+49.29%
273.29
-26.58%
372.21
Working Capital
260.25
+2.29%
254.42
+10.74%
229.74
-32.16%
338.64
Invested Capital
312.32
-23.45%
407.97
+49.28%
273.29
-26.58%
372.21
Total Debt
76.42
-4.80%
80.27
-9.13%
88.34
+6.52%
82.93
Capital Lease Obligations
76.42
-4.80%
80.27
-9.13%
88.34
+6.52%
82.93
Net Tangible Assets
312.32
-23.45%
407.98
+49.29%
273.29
-26.58%
372.21
Tangible Book Value
312.32
-23.45%
407.97
+49.28%
273.29
-26.58%
372.21
Available For Sale Securities
16.11
-85.41%
110.39
—
—
Investmentin Financial Assets
16.11
-85.41%
110.39
0.00
—
Preferred Stock Equity
0.01
+0.00%
0.01
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-88.70
+11.03%
-99.70
-15.71%
-86.16
-51.16%
-57.00
Cash Flow From Continuing Operating Activities
-88.70
+11.03%
-99.70
-15.71%
-86.16
-51.16%
-57.00
Net Income From Continuing Operations
-104.08
+4.33%
-108.79
+7.41%
-117.50
-3.22%
-113.84
Depreciation Amortization Depletion
9.19
+0.45%
9.15
+55.94%
5.87
+122.56%
2.64
Depreciation And Amortization
9.19
+0.45%
9.15
+55.94%
5.87
+122.56%
2.64
Other Non Cash Items
1.95
-14.65%
2.29
+2.88%
2.22
-43.53%
3.94
Stock Based Compensation
8.56
-48.84%
16.73
-2.72%
17.20
+2.03%
16.86
Asset Impairment Charge
0.79
0.00
-100.00%
4.10
0.00
Operating Gains Losses
-0.09
—
-0.03
-106.94%
0.49
Gain Loss On Investment Securities
-0.09
—
-0.03
-106.94%
0.49
Change In Working Capital
-0.43
+96.42%
-12.16
-211.33%
10.93
-67.62%
33.74
Change In Prepaid Assets
2.11
+254.80%
-1.36
-179.55%
1.72
+215.25%
-1.49
Change In Payables And Accrued Expense
2.46
+155.11%
-4.47
-205.83%
4.22
+53.17%
2.76
Change In Payable
2.46
+155.11%
-4.47
-205.83%
4.22
+53.17%
2.76
Change In Account Payable
2.46
+155.11%
-4.47
-205.83%
4.22
+53.17%
2.76
Change In Other Current Liabilities
-5.01
+20.82%
-6.33
-226.94%
4.99
-84.64%
32.47
Investing Cash Flow
100.32
+177.43%
-129.56
-263.96%
79.02
+142.78%
-184.69
Cash Flow From Continuing Investing Activities
100.32
+177.43%
-129.56
-263.96%
79.02
+142.78%
-184.69
Net PPE Purchase And Sale
-1.21
+72.60%
-4.41
+84.34%
-28.15
+40.25%
-47.11
Purchase Of PPE
-1.21
+72.60%
-4.41
+84.34%
-28.15
+40.25%
-47.11
Capital Expenditure
-1.21
+72.60%
-4.41
+84.34%
-28.15
+40.25%
-47.11
Net Investment Purchase And Sale
101.53
+181.13%
-125.15
-216.78%
107.16
+177.89%
-137.58
Purchase Of Investment
-238.56
+41.29%
-406.38
-56.16%
-260.23
+32.56%
-385.89
Sale Of Investment
340.09
+20.93%
281.23
-23.45%
367.39
+47.96%
248.31
Financing Cash Flow
0.14
-99.94%
226.08
+32618.38%
0.69
-99.68%
219.01
Cash Flow From Continuing Financing Activities
0.14
-99.94%
226.08
+32618.38%
0.69
-99.68%
219.01
Net Common Stock Issuance
0.00
-100.00%
225.07
0.00
-100.00%
217.17
Proceeds From Stock Option Exercised
0.14
-86.05%
1.01
+46.31%
0.69
-62.49%
1.84
Net Other Financing Charges
—
—
—
—
Changes In Cash
11.76
+471.36%
-3.17
+50.93%
-6.45
+71.54%
-22.68
Beginning Cash Position
30.62
-9.37%
33.78
-16.04%
40.24
-36.04%
62.91
End Cash Position
42.38
+38.41%
30.62
-9.37%
33.78
-16.04%
40.24
Free Cash Flow
-89.91
+13.64%
-104.11
+8.93%
-114.31
-9.79%
-104.11
Amortization Of Securities
-4.58
+33.74%
-6.91
+22.68%
-8.94
-992.91%
-0.82
Common Stock Issuance
0.00
-100.00%
225.07
0.00
-100.00%
217.17
Issuance Of Capital Stock
0.00
-100.00%
225.07
0.00
-100.00%
217.17
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category